Your browser doesn't support javascript.
loading
Efavirenz but Not Atazanavir/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected Subjects.
Calderón, Mónica M; Penzak, Scott R; Pau, Alice K; Kumar, Parag; McManus, Maryellen; Alfaro, Raul M; Kovacs, Joseph A.
Afiliação
  • Calderón MM; Pharmacy Department, National Institutes of Health (NIH) Clinical Center, Bethesda.
  • Penzak SR; Leidos Biomedical Research, Inc, National Cancer Institute at Frederick.
  • Pau AK; Pharmacy Department, National Institutes of Health (NIH) Clinical Center, Bethesda.
  • Kumar P; National Institute of Allergy and Infectious Diseases, NIH.
  • McManus M; Pharmacy Department, National Institutes of Health (NIH) Clinical Center, Bethesda.
  • Alfaro RM; Leidos Biomedical Research, Inc, National Cancer Institute at Frederick.
  • Kovacs JA; Pharmacy Department, National Institutes of Health (NIH) Clinical Center, Bethesda.
Clin Infect Dis ; 62(8): 1036-1042, 2016 Apr 15.
Article em En | MEDLINE | ID: mdl-26797214

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ritonavir / Fármacos Anti-HIV / Benzoxazinas / Atovaquona / Anti-Infecciosos Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ritonavir / Fármacos Anti-HIV / Benzoxazinas / Atovaquona / Anti-Infecciosos Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2016 Tipo de documento: Article